XTL Biopharmaceuticals Owners

Health Care & Life Sciences » Biotechnology | XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. ADR | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

G1 Execution Services LLC

40,679

0.79%

40,679

06/30/2018

Invesco Asset Management Ltd.

25,961

0.51%

06/30/2018

Morgan Stanley & Co. LLC

20,161

0.39%

4,300

06/30/2018

Citadel Advisors LLC

17,312

0.34%

17,312

06/30/2018

IBI Mutual Funds Management (1978) Ltd.

8,060

0.16%

06/28/2018

UBS Securities LLC

692

0.01%

-437

06/30/2018

Bank of America, NA (Private Banking)

-1,000

06/30/2018

View Profile

Address	5 Badner Sreet Ramat Gan HM 4365603 Israel
Employees	-
Website	http://www.xtlbio.com
Updated	07/08/2019
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.